Format

Send to

Choose Destination
See comment in PubMed Commons below
Bone Marrow Transplant. 2013 Aug;48(8):1046-9. doi: 10.1038/bmt.2013.8. Epub 2013 Feb 18.

Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation.

Author information

1
Medicine, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN 55455, USA.

Abstract

Recent advances in allogeneic hematopoietic cell transplant (allo-HCT) have led to an increasing use of alternative donors, including banked umbilical cord blood (UCB). Despite these advances, acute GVHD (aGVHD) and chronic GVHD (cGVHD) continue to be the leading causes of early and late transplant-related mortality. ABO-mismatch has been frequently reported as a risk factor for GVHD, however, data in the UCB recipients are limited. We hypothesized that as the lymphocytes in the cord blood are thought to be naive, they will therefore be less likely to mediate GVHD. Therefore, we analyzed the impact of ABO-mismatch on aGVHD and cGVHD in recipients of single and double UCB-HCT. In both univariate and multivariate analyses, presence of ABO-mismatch did not have an impact on aGVHD or cGVHD. Whereas ABO-compatible donors are preferred in recipients of URD-HCT, ABO compatibility generally need not be considered in recipients of UCB-HCT.

PMID:
23419434
PMCID:
PMC3740145
DOI:
10.1038/bmt.2013.8
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center